Loading...
INDEX: NASDAQ
SYMBOL: VKTX
NAME: Viking Therapeutics Inc
UPVOTES: 16
DOWNVOTES: 14


Description

Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company focuses on the development of therapies for metabolic and endocrine disorders. The Company's clinical program, VK5211, is an orally available drug candidate, which is in Phase II clinical trial for acute rehabilitation following non-elective hip fracture surgery. VK5211 is a non-steroidal selective androgen receptor modulator (SARM). Its second program is focused on the development of orally available small molecule thyroid hormone receptor beta agonists. Its two molecules are VK2809 and VK0214. VK2809 is an orally available, tissue and receptor-subtype selective agonist of the thyroid beta receptor that is entering Phase II development for the treatment of patients with hypercholesterolemia and fatty liver disease. It is developing VK0214 for the treatment of X-linked adrenoleukodystrophy (X-ALD). It has a pipeline with approximately three additional programs targeting metabolic diseases and anemia.

Read Full Descript at Reuters

VKTX Message Board



Todays Most
Up-Voted
Todays Most
Down-Voted
Most
Recent Voted
All Time Most
Up-Voted
All Time Most
Down-Voted
Top
Voted Index

NASDAQ



Stock SymbolUp VotesDown VotesVote
ACB30
ARCB20
AUMN10
AMER21
ALQA10
ADMS10
ACET11
APAFF01
AREX01
AIM01
Stock SymbolUp VotesDown VotesVote
TSLA319106
CBIS306131
AMD288221
DIS15896
NVDA14489
AMZN15299
KTOS12781
NFLX12685
MSRT13091
NAT9661
Stock SymbolUp VotesDown VotesVote
ALIM52
AGNC63
ACB52
ARCB63
TKSTF31
AMDA42
AXS53
ATTBF42
AMER53
ACAD42
Stock SymbolUp VotesDown VotesVote
SDVI189
AGNC126
ARCB1410
AAPL128
ALIM85
ACAD85
A96
QSEP63
AXS108
IPG31
Stock SymbolUp VotesDown VotesVote
TSLA319106
CBIS306131
AMD288221
DIS15896
NVDA14489
AMZN15299
KTOS12781
NFLX12685
MSRT13091
NAT9661

Last 10 Stocks Voted On

Stock SymbolActionVote
ACETUPVOTE
AMERDOWNVOTE
AMERUPVOTE
ACETDOWNVOTE
AGMDOWNVOTE
AETDOWNVOTE
ARCBUPVOTE
ALQAUPVOTE
ARCBUPVOTE
ACBUPVOTE